ClinicalTrials.Veeva

Menu
A

Avicenna Clinical Research | Southwest Gastroenterology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Risankizumab
Etrolizumab
Relamorelin
CP-690,550
Metoclopramide
RPC4046
Ustekinumab
695501
CIN-103
Vedolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 29 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankiz...

Active, not recruiting
Crohn's Disease (CD)
Drug: Risankizumab
Drug: Ustekinumab

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Enrolling
Irritable Bowel Syndrome With Diarrhea
Drug: CIN-103
Drug: Placebo

Trial sponsors

AbbVie logo
Allergan logo
Exact Sciences Corporation logo
Roche logo
Pfizer logo
E
A
A
Boehringer Ingelheim logo
Celgene logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems